Trial intelligence / Profile preview

Intranasal insulin in children with Phelan-McDermid syndrome

2012-002873-77Phase 2Active

Sponsor
University Medical Center Groningen
Start
Nov 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, single-arm trial of human insulin in Phelan-McDermid syndrome (PMS), sponsored by University Medical Center Groningen. Primary endpoint: Developmental pace. Started Nov 2012; status: active.

02

Drugs

human insulin
03

Conditions

Phelan-McDermid syndrome (PMS)

Beyond the preview

Go deeper on 2012-002873-77.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002873-77.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call